中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2010年
29期
2040-2043
,共4页
朱双根%朱幼玲%周志明%刘文华%殷勤%马敏敏%樊小兵%徐格林%刘新峰
硃雙根%硃幼玲%週誌明%劉文華%慇勤%馬敏敏%樊小兵%徐格林%劉新峰
주쌍근%주유령%주지명%류문화%은근%마민민%번소병%서격림%류신봉
颅内动脉%动脉粥样硬化%支架成形术%再狭窄%血管造影
顱內動脈%動脈粥樣硬化%支架成形術%再狹窄%血管造影
로내동맥%동맥죽양경화%지가성형술%재협착%혈관조영
Intracranial artery%Atherosclerosis%Stenting%Restenosis%Angiography
目的 评价病变长度对颅内动脉支架成形术后再狭窄的影响.方法 选取2004年3月至2009年9月成功实施球扩金属裸支架置入术治疗症状性颅内动脉粥样硬化性狭窄的住院患者65例,所有患者均行脑血管造影复查.按病变长度分为3组:短病变组(<5 mm),中等长度病变组(5~10 mm)和长病变组(>10 mm).支架内再狭窄定义为管腔狭窄>50%或者管腔直径绝对值减少超过20%.分析不同病变长度对再狭窄的影响,并采用多元Cox回归逐步筛选出预测支架内再狭窄的独立风险因素.结果 短病变组、中等长度病变组和长病变组各组病例数分别为28例、29例和8例.血管造影随访中位数时间为7个月(5~30个月),有19例发生再狭窄(29.2%).3组再狭窄率依次为:14.3%、37.9%和50%(P=0.045).Cox回归多因素分析显示病变长度[风险比(HR)=1.210,95%可信区间(CI)=1.011~1.446,P=0.037]和糖尿病(HR=2.630,95%CI=1.032~6.705,P=0.043)与再狭窄有关.结论 病变长度和糖尿病是颅内动脉支架成形术后再狭窄的独立风险因素.
目的 評價病變長度對顱內動脈支架成形術後再狹窄的影響.方法 選取2004年3月至2009年9月成功實施毬擴金屬裸支架置入術治療癥狀性顱內動脈粥樣硬化性狹窄的住院患者65例,所有患者均行腦血管造影複查.按病變長度分為3組:短病變組(<5 mm),中等長度病變組(5~10 mm)和長病變組(>10 mm).支架內再狹窄定義為管腔狹窄>50%或者管腔直徑絕對值減少超過20%.分析不同病變長度對再狹窄的影響,併採用多元Cox迴歸逐步篩選齣預測支架內再狹窄的獨立風險因素.結果 短病變組、中等長度病變組和長病變組各組病例數分彆為28例、29例和8例.血管造影隨訪中位數時間為7箇月(5~30箇月),有19例髮生再狹窄(29.2%).3組再狹窄率依次為:14.3%、37.9%和50%(P=0.045).Cox迴歸多因素分析顯示病變長度[風險比(HR)=1.210,95%可信區間(CI)=1.011~1.446,P=0.037]和糖尿病(HR=2.630,95%CI=1.032~6.705,P=0.043)與再狹窄有關.結論 病變長度和糖尿病是顱內動脈支架成形術後再狹窄的獨立風險因素.
목적 평개병변장도대로내동맥지가성형술후재협착적영향.방법 선취2004년3월지2009년9월성공실시구확금속라지가치입술치료증상성로내동맥죽양경화성협착적주원환자65례,소유환자균행뇌혈관조영복사.안병변장도분위3조:단병변조(<5 mm),중등장도병변조(5~10 mm)화장병변조(>10 mm).지가내재협착정의위관강협착>50%혹자관강직경절대치감소초과20%.분석불동병변장도대재협착적영향,병채용다원Cox회귀축보사선출예측지가내재협착적독립풍험인소.결과 단병변조、중등장도병변조화장병변조각조병례수분별위28례、29례화8례.혈관조영수방중위수시간위7개월(5~30개월),유19례발생재협착(29.2%).3조재협착솔의차위:14.3%、37.9%화50%(P=0.045).Cox회귀다인소분석현시병변장도[풍험비(HR)=1.210,95%가신구간(CI)=1.011~1.446,P=0.037]화당뇨병(HR=2.630,95%CI=1.032~6.705,P=0.043)여재협착유관.결론 병변장도화당뇨병시로내동맥지가성형술후재협착적독립풍험인소.
Objective To evaluate the effect of lesion length on in-stent restenosis (ISR) after intracranial stenting. Methods Between March 2004 and September 2009, 65 patients with symptomatic intracranial arterial stenosis were successfully implanted with single bare metal balloon-mounted stent. All received a conventional angiographic follow-up. The patients were divided into three groups according to lesion length: short lesions ( <5 mm), medium lesions (5-10 mm) and long lesions ( >10 mm). ISR was defined as > 50% stenosis within stent or absolute luminal loss > 20%. The influence of different lesion lengths on ISR was evaluated. Furthermore, the independent predictive factors for ISR were selected. Results There were short lesions ( n = 28 ), medium lesions ( n = 29 ) and long lesions ( n = 8 ). The median interval of angiographic follow-up was 7 months with a range of 5-30 months. Of 65 patients, 19 (29.2%) had ISR. The ISR rates were 14.3%, 37.9% and 50% in short lesions, medium lesions and long lesions respectively ( P = 0. 045 ). Multivariate Cox regression analysis showed that lesion length ( HR = 1.210; 95% CI= 1.011-1.446; P =0.037) and diabetes (HR=2.630; 95% CI= 1.032-6.705; P= 0. 043) were associated with ISR. Conclusion Lesion length and diabetes are two independent predictors for ISR after intracranial stenting.